USPTO trademark

EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION

Under examinationUSPTOWord markClass 41Class 44

"EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION" is a word mark owned by Ionis Pharmaceuticals, Inc., filed at the USPTO on June 24, 2026. It is under examination and covers classes 41 and 44.

View Ionis Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION trademark as filed
As filed with the USPTO
Status
Under examination
Since June 24, 2026
Filed
June 24, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99903171
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Ionis Pharmaceuticals, Inc.

IONS · Carlsbad, United States

161 trademarks in the portfolioView company

Representative

Brian J. Focarino

Cooley LLP

Goods and services

What the mark covers

The products and services EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION is filed for, grouped by Nice class.

  • Education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the fields of genetic diseases and disorders, cardiovascular, inflammatory, metabolic, and rare diseases and disorders, lipids, triglycerides, body fat, lipoproteins, heart disease, fatty liver disease, and pancreatitis; online journals, namely, blogs featuring information on genetic diseases and disorders, cardiovascular, inflammatory, metabolic, and rare diseases and disorders, lipids, triglycerides, body fat, lipoproteins, heart disease, fatty liver disease, and pancreatitis; providing a website featuring blogs and non-downloadable publications in the nature of articles, blogs, brochures, and guides in the fields of cardiovascular, inflammatory, metabolic, and rare diseases and disorders, lipids, triglycerides, body fat, lipoproteins, heart disease, fatty liver disease, and pancreatitis

  • Patient advisory, healthcare professional, and caregiver support services regarding, and consultancy services regarding access to, medical treatment of genetic diseases and disorders, cardiovascular, metabolic, inflammatory, and rare diseases and disorders, lipids, triglycerides, body fat, lipoproteins, heart disease, fatty liver disease, and pancreatitis

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION

Who owns the trademark "EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION"?

The USPTO trademark "EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION" (application 99903171) is owned by Ionis Pharmaceuticals, Inc.

What is the status of "EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019efeee-4739-7589-b6ff-0ac2edbd4a53
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019efeee-4739-7589-b6ff-0ac2edbd4a53",
  "object": "trademark",
  "mark_text": "EXPAND WHAT'S POSSIBLE IN TRIGLYCERIDE REDUCTION",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99903171",
  "filing_date": "2026-06-24",
  "nice_classes": [
    41,
    44
  ],
  "owners": [
    {
      "name": "Ionis Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb70a-07fc-72dc-92fe-29d61c5dd741"
    }
  ]
}